| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Neuroscience Center and Department of Pharmacology, Louisiania State University Health Sciences Center, New Orleans, Louisiana 70112, USA
1Correspondence: LSUHSC/Neuroscience, 2020 Gravier St., Suite D, New Orleans, LA 70112, USA. E-mail: jerick{at}lsumc.edu
Vesicular transporters are responsible for the loading of neurotransmitters into specialized secretory organelles in neurons and neuroendocrine cells to make them available for regulated neurosecretion. The exocytotic release of neurotransmitter therefore depends on the functional activity of the vesicular transporters and their efficient sorting to these secretory organelles. Molecular analysis of vesicular transport proteins has revealed important information regarding structural domains responsible for their functional properties, including substrate specificity and trafficking to various classes of secretory vesicles. These studies have established the existence of an important functional relationship between transporter activity and presynaptic quantal neurosecretion.—Erickson, J. D., Varoqui, H. Molecular analysis of vesicular amine transporter function and targeting to secretory organelles.
Key Words: CAD • PC12 • biogenic amines • acetylcholine • small synaptic vesicle • large dense core vesicle • synaptic-like microvesicle • trafficking • quantal release
This article has been cited by other articles:
|
|
 |
|
  A. Gopalakrishnan, M. Sievert, and A. E. Ruoho Identification of the Substrate Binding Region of Vesicular Monoamine Transporter-2 (VMAT-2) Using Iodoaminoflisopolol as a Novel Photoprobe Mol. Pharmacol., December 1, 2007; 72(6): 1567 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Anlauf, M. K.-H. Schafer, T. Schwark, N. von Wurmb-Schwark, V. Brand, B. Sipos, H.-P. Horny, R. Parwaresch, W. Hartschuh, L. E. Eiden, et al. Vesicular Monoamine Transporter 2 (VMAT2) Expression in Hematopoietic Cells and in Patients with Systemic Mastocytosis J. Histochem. Cytochem., February 1, 2006; 54(2): 201 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Essand, S Vikman, J Grawe, L Gedda, C Hellberg, K Oberg, T H Totterman, and V Giandomenico Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1 J. Mol. Endocrinol., December 1, 2005; 35(3): 489 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Anlauf, M. K.-H. Schafer, C. Depboylu, W. Hartschuh, L. E. Eiden, G. Kloppel, and E. Weihe The Vesicular Monoamine Transporter 2 (VMAT2) Is Expressed by Normal and Tumor Cutaneous Mast Cells and Langerhans Cells of the Skin but Is Absent from Langerhans Cell Histiocytosis J. Histochem. Cytochem., June 1, 2004; 52(6): 779 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Anlauf, R. Eissele, M. K.-H. Schafer, L. E. Eiden, R. Arnold, U. Pauser, G. Kloppel, and E. Weihe Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors J. Histochem. Cytochem., August 1, 2003; 51(8): 1027 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gras, E. Herzog, G. C. Bellenchi, V. Bernard, P. Ravassard, M. Pohl, B. Gasnier, B. Giros, and S. El Mestikawy A Third Vesicular Glutamate Transporter Expressed by Cholinergic and Serotoninergic Neurons J. Neurosci., July 1, 2002; 22(13): 5442 - 5451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. EIDEN The vesicular neurotransmitter transporters: current perspectives and future prospects FASEB J, December 1, 2000; 14(15): 2396 - 2400. [Full Text]
|
|
|
|
 |
|
 D. S. Thiriot and A. E. Ruoho Mutagenesis and Derivatization of Human Vesicle Monoamine Transporter 2 (VMAT2) Cysteines Identifies Transporter Domains Involved in Tetrabenazine Binding and Substrate Transport J. Biol. Chem., July 13, 2001; 276(29): 27304 - 27315. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
